Van Taylor sold Biomarin Pharmaceutical Inc (NASDAQ: BMRN)
Van Taylor (R-TX), a U.S. Representative, has disclosed 1 trade in Biomarin Pharmaceutical Inc (BMRN) since 2019, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Van Taylor sold $1,001 - $15,000 of Biomarin Pharmaceutical Inc (NASDAQ: BMRN) on March 25, 2019. Since that trade, BMRN is down -31.59% against the S&P 500 up +195.07%, an outperformance of -226.65%.
Data updated
Van Taylor's BMRN trades vs the price
BMRN is down -31.59% since Van Taylor sold on March 25, 2019, versus +195.07% for the S&P 500.
Performance since this trade
All Van Taylor BMRN trades
Van Taylor & BMRN trading FAQ
Is it legal for Van Taylor to trade Biomarin Pharmaceutical Inc (BMRN) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Biomarin Pharmaceutical Inc (BMRN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Van Taylor sell BMRN?
Van Taylor disclosed a sale of $1,001 - $15,000 of Biomarin Pharmaceutical Inc (BMRN) on March 25, 2019, according to public STOCK Act filings.
How has BMRN performed since Van Taylor's trade?
Since Van Taylor sold BMRN on March 25, 2019, the stock is down -31.59%, versus +195.07% for the S&P 500 over the same period, an outperformance of -226.65%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional BMRN trades?
Quantellect tracks every disclosed congressional trade in Biomarin Pharmaceutical Inc (BMRN) on the Biomarin Pharmaceutical Inc congressional trading page, which aggregates filings across all members of Congress.
Van Taylor's BMRN tradesAll congressional filings for Biomarin Pharmaceutical IncVan Taylor's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.